APO Research
Talk to an analyst

APO RESEARCH · REPORT

Brain Disease Device and Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Brain Disease Device and Software Market Outlook and Growth Opportunities 2026

1 January 2026209 pages

Choose your research edition.

Industry ResearchBrain Disease Device and Software Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Brain Disease Device and Software Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Brain Disease Device and Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Brain Disease Device and Software Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Brain Disease Device and Software Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Brain Disease Device and Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Brain Disease Device and Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Brain Disease Device and Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Brain Disease Device and Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Brain Disease Device and Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Brain Disease Device and Software market include United Imaging Healthcare Co., Ltd, Koninklijke Philips N.V., GE, Canon, Inc, Siemens Healthineers AG, Vuno Co., Ltd, Fujifilm Holdings Corporation, Aspect Imaging and IXICO, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Brain Disease Device and Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Brain Disease Device and Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Brain Disease Device and Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Brain Disease Device and Software market.

Brain Disease Device and Software Segment by Company

United Imaging Healthcare Co., Ltd

Koninklijke Philips N.V.

GE

Canon, Inc

Siemens Healthineers AG

Vuno Co., Ltd

Fujifilm Holdings Corporation

Aspect Imaging

IXICO

QMENTA

Cortechs.ai

Quantib

Brainomix

Qure.AI

Imaging Biometrics, LLC

A.I. Analysis, Inc

Brain Disease Device and Software Segment by Type

Brain Disease Device

Brain Disease Software

Brain Disease Device and Software Segment by Application

Hospitals and Clinics

Diagnostic Imaging Centers

Ambulatory Surgical Centers

Brain Disease Device and Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Brain Disease Device and Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Brain Disease Device and Software key companies, revenue, market share, and recent developments.

3. To split the Brain Disease Device and Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Brain Disease Device and Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Brain Disease Device and Software significant trends, drivers, influence factors in global and regions.

6. To analyze Brain Disease Device and Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brain Disease Device and Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Brain Disease Device and Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brain Disease Device and Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Brain Disease Device and Software industry.

Chapter 3: Detailed analysis of Brain Disease Device and Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Brain Disease Device and Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Brain Disease Device and Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Brain Disease Device and Software Industry Trends Table 2. Brain Disease Device and Software Industry Drivers Table 3. Brain Disease Device and Software Industry Opportunities and Challenges Table 4. Brain Disease Device and Software Industry Restraints Table 5. Global Brain Disease Device and Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Brain Disease Device and Software Revenue Share by Company (2021-2026) Table 7. Global Brain Disease Device and Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Brain Disease Device and Software Key Company Manufacturing Base & Headquarters Table 9. Global Brain Disease Device and Software Company, Product Type & Application Table 10. Global Brain Disease Device and Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Brain Disease Device and Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Brain Disease Device Table 15. Significant Companies of Brain Disease Software Table 16. Global Brain Disease Device and Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Brain Disease Device and Software Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Brain Disease Device and Software Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Brain Disease Device and Software Sales Value Share by Type (2021-2026) Table 20. Global Brain Disease Device and Software Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospitals and Clinics Table 22. Significant Companies of Diagnostic Imaging Centers Table 23. Significant Companies of Ambulatory Surgical Centers Table 24. Global Brain Disease Device and Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Brain Disease Device and Software Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Brain Disease Device and Software Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Brain Disease Device and Software Sales Value Share by Application (2021-2026) Table 28. Global Brain Disease Device and Software Sales Value Share by Application (2027-2032) Table 29. Global Brain Disease Device and Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Brain Disease Device and Software Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Brain Disease Device and Software Sales Value Share by Region (2021-2026) Table 32. Global Brain Disease Device and Software Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Brain Disease Device and Software Sales Value Share by Region (2027-2032) Table 34. Global Brain Disease Device and Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Brain Disease Device and Software Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Brain Disease Device and Software Sales Value Market Share by Country (2021-2026) Table 37. Global Brain Disease Device and Software Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Brain Disease Device and Software Sales Value Market Share by Country (2027-2032) Table 39. United Imaging Healthcare Co., Ltd Company Information Table 40. United Imaging Healthcare Co., Ltd Business Overview Table 41. United Imaging Healthcare Co., Ltd Brain Disease Device and Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. United Imaging Healthcare Co., Ltd Brain Disease Device and Software Product Portfolio Table 43. United Imaging Healthcare Co., Ltd Recent Development Table 44. Koninklijke Philips N.V. Company Information Table 45. Koninklijke Philips N.V. Business Overview Table 46. Koninklijke Philips N.V. Brain Disease Device and Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Koninklijke Philips N.V. Brain Disease Device and Software Product Portfolio Table 48. Koninklijke Philips N.V. Recent Development Table 49. GE Company Information Table 50. GE Business Overview Table 51. GE Brain Disease Device and Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. GE Brain Disease Device and Software Product Portfolio Table 53. GE Recent Development Table 54. Canon, Inc Company Information Table 55. Canon, Inc Business Overview Table 56. Canon, Inc Brain Disease Device and Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Canon, Inc Brain Disease Device and Software Product Portfolio Table 58. Canon, Inc Recent Development Table 59. Siemens Healthineers AG Company Information Table 60. Siemens Healthineers AG Business Overview Table 61. Siemens Healthineers AG Brain Disease Device and Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Siemens Healthineers AG Brain Disease Device and Software Product Portfolio Table 63. Siemens Healthineers AG Recent Development Table 64. Vuno Co., Ltd Company Information Table 65. Vuno Co., Ltd Business Overview Table 66. Vuno Co., Ltd Brain Disease Device and Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Vuno Co., Ltd Brain Disease Device and Software Product Portfolio Table 68. Vuno Co., Ltd Recent Development Table 69. Fujifilm Holdings Corporation Company Information Table 70. Fujifilm Holdings Corporation Business Overview Table 71. Fujifilm Holdings Corporation Brain Disease Device and Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Fujifilm Holdings Corporation Brain Disease Device and Software Product Portfolio Table 73. Fujifilm Holdings Corporation Recent Development Table 74. Aspect Imaging Company Information Table 75. Aspect Imaging Business Overview Table 76. Aspect Imaging Brain Disease Device and Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Aspect Imaging Brain Disease Device and Software Product Portfolio Table 78. Aspect Imaging Recent Development Table 79. IXICO Company Information Table 80. IXICO Business Overview Table 81. IXICO Brain Disease Device and Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. IXICO Brain Disease Device and Software Product Portfolio Table 83. IXICO Recent Development Table 84. QMENTA Company Information Table 85. QMENTA Business Overview Table 86. QMENTA Brain Disease Device and Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. QMENTA Brain Disease Device and Software Product Portfolio Table 88. QMENTA Recent Development Table 89. Cortechs.ai Company Information Table 90. Cortechs.ai Business Overview Table 91. Cortechs.ai Brain Disease Device and Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Cortechs.ai Brain Disease Device and Software Product Portfolio Table 93. Cortechs.ai Recent Development Table 94. Quantib Company Information Table 95. Quantib Business Overview Table 96. Quantib Brain Disease Device and Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Quantib Brain Disease Device and Software Product Portfolio Table 98. Quantib Recent Development Table 99. Brainomix Company Information Table 100. Brainomix Business Overview Table 101. Brainomix Brain Disease Device and Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Brainomix Brain Disease Device and Software Product Portfolio Table 103. Brainomix Recent Development Table 104. Qure.AI Company Information Table 105. Qure.AI Business Overview Table 106. Qure.AI Brain Disease Device and Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Qure.AI Brain Disease Device and Software Product Portfolio Table 108. Qure.AI Recent Development Table 109. Imaging Biometrics, LLC Company Information Table 110. Imaging Biometrics, LLC Business Overview Table 111. Imaging Biometrics, LLC Brain Disease Device and Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Imaging Biometrics, LLC Brain Disease Device and Software Product Portfolio Table 113. Imaging Biometrics, LLC Recent Development Table 114. A.I. Analysis, Inc Company Information Table 115. A.I. Analysis, Inc Business Overview Table 116. A.I. Analysis, Inc Brain Disease Device and Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. A.I. Analysis, Inc Brain Disease Device and Software Product Portfolio Table 118. A.I. Analysis, Inc Recent Development Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Brain Disease Device and Software Product Image Figure 2. Global Brain Disease Device and Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Brain Disease Device and Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Brain Disease Device and Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Brain Disease Device Image Figure 8. Brain Disease Software Image Figure 9. Global Brain Disease Device and Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Brain Disease Device and Software Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Brain Disease Device and Software Sales Value Share by Type (2021-2032) Figure 12. Hospitals and Clinics Image Figure 13. Diagnostic Imaging Centers Image Figure 14. Ambulatory Surgical Centers Image Figure 15. Global Brain Disease Device and Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Brain Disease Device and Software Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Brain Disease Device and Software Sales Value Share by Application (2021-2032) Figure 18. Global Brain Disease Device and Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Brain Disease Device and Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Brain Disease Device and Software Sales Value (2021-2032) & (US$ Million) Figure 21. North America Brain Disease Device and Software Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Brain Disease Device and Software Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Brain Disease Device and Software Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Brain Disease Device and Software Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Brain Disease Device and Software Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Brain Disease Device and Software Sales Value (2021-2032) & (US$ Million) Figure 27. South America Brain Disease Device and Software Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Brain Disease Device and Software Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Brain Disease Device and Software Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Brain Disease Device and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Brain Disease Device and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Brain Disease Device and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Brain Disease Device and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Brain Disease Device and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Brain Disease Device and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Brain Disease Device and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Brain Disease Device and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Brain Disease Device and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Brain Disease Device and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Brain Disease Device and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Brain Disease Device and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Brain Disease Device and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Brain Disease Device and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Brain Disease Device and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Brain Disease Device and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Brain Disease Device and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Brain Disease Device and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Brain Disease Device and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Brain Disease Device and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Brain Disease Device and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Brain Disease Device and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Brain Disease Device and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Brain Disease Device and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Brain Disease Device and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Brain Disease Device and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Brain Disease Device and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Brain Disease Device and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Brain Disease Device
  • Brain Disease Software
Applications
  • Hospitals and Clinics
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers
Companies covered
  • United Imaging Healthcare Co., Ltd
  • Koninklijke Philips N.V.
  • GE
  • Canon, Inc
  • Siemens Healthineers AG
  • Vuno Co., Ltd
  • Fujifilm Holdings Corporation
  • Aspect Imaging
  • IXICO
  • QMENTA
  • Cortechs.ai
  • Quantib
  • Brainomix
  • Qure.AI
  • Imaging Biometrics, LLC
  • A.I. Analysis, Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Brain Disease Device and Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Brain Disease Device and Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Brain Disease Device and Software Market Dynamics
  1. 2.1 Brain Disease Device and Software Industry Trends
  2. 2.2 Brain Disease Device and Software Industry Drivers
  3. 2.3 Brain Disease Device and Software Industry Opportunities and Challenges
  4. 2.4 Brain Disease Device and Software Industry Restraints
3 Brain Disease Device and Software Market by Company
  1. 3.1 Global Brain Disease Device and Software Company Revenue Ranking in 2025
  2. 3.2 Global Brain Disease Device and Software Revenue by Company (2021-2026)
  3. 3.3 Global Brain Disease Device and Software Company Ranking (2024-2026)
  4. 3.4 Global Brain Disease Device and Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Brain Disease Device and Software Company Product Type and Application
  6. 3.6 Global Brain Disease Device and Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Brain Disease Device and Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Brain Disease Device and Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Brain Disease Device and Software Market by Type
  1. 4.1 Brain Disease Device and Software Type Introduction
  2. 4.1.1 Brain Disease Device
  3. 4.1.2 Brain Disease Software
  4. 4.2 Global Brain Disease Device and Software Sales Value by Type
  5. 4.2.1 Global Brain Disease Device and Software Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Brain Disease Device and Software Sales Value by Type (2021-2032)
  7. 4.2.3 Global Brain Disease Device and Software Sales Value Share by Type (2021-2032)
5 Brain Disease Device and Software Market by Application
  1. 5.1 Brain Disease Device and Software Application Introduction
  2. 5.1.1 Hospitals and Clinics
  3. 5.1.2 Diagnostic Imaging Centers
  4. 5.1.3 Ambulatory Surgical Centers
  5. 5.2 Global Brain Disease Device and Software Sales Value by Application
  6. 5.2.1 Global Brain Disease Device and Software Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Brain Disease Device and Software Sales Value by Application (2021-2032)
  8. 5.2.3 Global Brain Disease Device and Software Sales Value Share by Application (2021-2032)
6 Brain Disease Device and Software Regional Value Analysis
  1. 6.1 Global Brain Disease Device and Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Brain Disease Device and Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Brain Disease Device and Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Brain Disease Device and Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Brain Disease Device and Software Sales Value (2021-2032)
  7. 6.3.2 North America Brain Disease Device and Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Brain Disease Device and Software Sales Value (2021-2032)
  10. 6.4.2 Europe Brain Disease Device and Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Brain Disease Device and Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Brain Disease Device and Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Brain Disease Device and Software Sales Value (2021-2032)
  16. 6.6.2 South America Brain Disease Device and Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Brain Disease Device and Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Brain Disease Device and Software Sales Value Share by Country, 2025 VS 2032
7 Brain Disease Device and Software Country-level Value Analysis
  1. 7.1 Global Brain Disease Device and Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Brain Disease Device and Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Brain Disease Device and Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Brain Disease Device and Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Brain Disease Device and Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Brain Disease Device and Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Brain Disease Device and Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Brain Disease Device and Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Brain Disease Device and Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Brain Disease Device and Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Brain Disease Device and Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Brain Disease Device and Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Brain Disease Device and Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Brain Disease Device and Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Brain Disease Device and Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Brain Disease Device and Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Brain Disease Device and Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Brain Disease Device and Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Brain Disease Device and Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Brain Disease Device and Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Brain Disease Device and Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Brain Disease Device and Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Brain Disease Device and Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Brain Disease Device and Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Brain Disease Device and Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Brain Disease Device and Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Brain Disease Device and Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Brain Disease Device and Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Brain Disease Device and Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Brain Disease Device and Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Brain Disease Device and Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Brain Disease Device and Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Brain Disease Device and Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Brain Disease Device and Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 United Imaging Healthcare Co., Ltd
  2. 8.1.1 United Imaging Healthcare Co., Ltd Company Information
  3. 8.1.2 United Imaging Healthcare Co., Ltd Business Overview
  4. 8.1.3 United Imaging Healthcare Co., Ltd Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 United Imaging Healthcare Co., Ltd Brain Disease Device and Software Product Portfolio
  6. 8.1.5 United Imaging Healthcare Co., Ltd Recent Developments
  7. 8.2 Koninklijke Philips N.V.
  8. 8.2.1 Koninklijke Philips N.V. Company Information
  9. 8.2.2 Koninklijke Philips N.V. Business Overview
  10. 8.2.3 Koninklijke Philips N.V. Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Koninklijke Philips N.V. Brain Disease Device and Software Product Portfolio
  12. 8.2.5 Koninklijke Philips N.V. Recent Developments
  13. 8.3 GE
  14. 8.3.1 GE Company Information
  15. 8.3.2 GE Business Overview
  16. 8.3.3 GE Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GE Brain Disease Device and Software Product Portfolio
  18. 8.3.5 GE Recent Developments
  19. 8.4 Canon, Inc
  20. 8.4.1 Canon, Inc Company Information
  21. 8.4.2 Canon, Inc Business Overview
  22. 8.4.3 Canon, Inc Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Canon, Inc Brain Disease Device and Software Product Portfolio
  24. 8.4.5 Canon, Inc Recent Developments
  25. 8.5 Siemens Healthineers AG
  26. 8.5.1 Siemens Healthineers AG Company Information
  27. 8.5.2 Siemens Healthineers AG Business Overview
  28. 8.5.3 Siemens Healthineers AG Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Siemens Healthineers AG Brain Disease Device and Software Product Portfolio
  30. 8.5.5 Siemens Healthineers AG Recent Developments
  31. 8.6 Vuno Co., Ltd
  32. 8.6.1 Vuno Co., Ltd Company Information
  33. 8.6.2 Vuno Co., Ltd Business Overview
  34. 8.6.3 Vuno Co., Ltd Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Vuno Co., Ltd Brain Disease Device and Software Product Portfolio
  36. 8.6.5 Vuno Co., Ltd Recent Developments
  37. 8.7 Fujifilm Holdings Corporation
  38. 8.7.1 Fujifilm Holdings Corporation Company Information
  39. 8.7.2 Fujifilm Holdings Corporation Business Overview
  40. 8.7.3 Fujifilm Holdings Corporation Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Fujifilm Holdings Corporation Brain Disease Device and Software Product Portfolio
  42. 8.7.5 Fujifilm Holdings Corporation Recent Developments
  43. 8.8 Aspect Imaging
  44. 8.8.1 Aspect Imaging Company Information
  45. 8.8.2 Aspect Imaging Business Overview
  46. 8.8.3 Aspect Imaging Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Aspect Imaging Brain Disease Device and Software Product Portfolio
  48. 8.8.5 Aspect Imaging Recent Developments
  49. 8.9 IXICO
  50. 8.9.1 IXICO Company Information
  51. 8.9.2 IXICO Business Overview
  52. 8.9.3 IXICO Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 IXICO Brain Disease Device and Software Product Portfolio
  54. 8.9.5 IXICO Recent Developments
  55. 8.10 QMENTA
  56. 8.10.1 QMENTA Company Information
  57. 8.10.2 QMENTA Business Overview
  58. 8.10.3 QMENTA Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 QMENTA Brain Disease Device and Software Product Portfolio
  60. 8.10.5 QMENTA Recent Developments
  61. 8.11 Cortechs.ai
  62. 8.11.1 Cortechs.ai Company Information
  63. 8.11.2 Cortechs.ai Business Overview
  64. 8.11.3 Cortechs.ai Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Cortechs.ai Brain Disease Device and Software Product Portfolio
  66. 8.11.5 Cortechs.ai Recent Developments
  67. 8.12 Quantib
  68. 8.12.1 Quantib Company Information
  69. 8.12.2 Quantib Business Overview
  70. 8.12.3 Quantib Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Quantib Brain Disease Device and Software Product Portfolio
  72. 8.12.5 Quantib Recent Developments
  73. 8.13 Brainomix
  74. 8.13.1 Brainomix Company Information
  75. 8.13.2 Brainomix Business Overview
  76. 8.13.3 Brainomix Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Brainomix Brain Disease Device and Software Product Portfolio
  78. 8.13.5 Brainomix Recent Developments
  79. 8.14 Qure.AI
  80. 8.14.1 Qure.AI Company Information
  81. 8.14.2 Qure.AI Business Overview
  82. 8.14.3 Qure.AI Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Qure.AI Brain Disease Device and Software Product Portfolio
  84. 8.14.5 Qure.AI Recent Developments
  85. 8.15 Imaging Biometrics, LLC
  86. 8.15.1 Imaging Biometrics, LLC Company Information
  87. 8.15.2 Imaging Biometrics, LLC Business Overview
  88. 8.15.3 Imaging Biometrics, LLC Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Imaging Biometrics, LLC Brain Disease Device and Software Product Portfolio
  90. 8.15.5 Imaging Biometrics, LLC Recent Developments
  91. 8.16 A.I. Analysis, Inc
  92. 8.16.1 A.I. Analysis, Inc Company Information
  93. 8.16.2 A.I. Analysis, Inc Business Overview
  94. 8.16.3 A.I. Analysis, Inc Brain Disease Device and Software Revenue and Gross Margin (2021-2026)
  95. 8.16.4 A.I. Analysis, Inc Brain Disease Device and Software Product Portfolio
  96. 8.16.5 A.I. Analysis, Inc Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst